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. Follicular helper T cells (T FH cells) have long been implicated in SLE pathogenesis. Yet a fraction of autoantibodies in individuals with
Activation of plasmacytoid dendritic cells (pDCs) with either chromatin-containing immune complexes 4, 5 or neutrophil-derived oxidized mitochondrial DNA (mtDNA) 3 leads to type I interferon (IFN) production. As antigen-presenting cells, pDCs also shape adaptive immune responses 6, 7 . Indeed, pDC activation with CpGA induces naive CD4 + T cells to become regulatory (type 1 regulatory T cells) 8 . Mechanistically, CpGA activates interferon regulatory factor 7 (IRF7)-related pathways but only minimally activates nuclear factor κ B (NF-κ B)-related pathways 9 , as detected by lower expression of interleukin-6 (IL-6) and CD86 as well as decreased p65 nuclear translocation compared with CpGB (Fig. 1a,b and Supplementary Fig. 1a-c) . Oxidized mtDNA exclusively triggers IFN production. Like CpGA, it upregulates major histocompatibility antigens (human leukocyte antigens (HLAs)), CD83 and CD40 (Fig. 1a,b and Supplementary Fig. 1a-d) . However, it uniquely induces the IL-3 receptor α -chain (CD123), which upon engagement with IL-3 promotes pDC survival 10 ( Fig. 1b and Supplementary Fig. 1e ). Activation of pDCs with either CpGA or oxidized mtDNA downregulates expression of the chemokine receptors CXCR4 and CXCR3 while increasing CCR7, which promotes migration to secondary lymphoid organs 11 ( Fig. 1b and Supplementary Fig. 1f ). To explore the biological outcome of activating pDCs with these two different toll-like receptor 9 ligands, we cocultured either type of activated pDC with naive CD4 + T cells (hereafter referred to as CpGA CD4
+ T cells and oxidized mtDNA CD4 + T cells, respectively). As a control we used naive CD4
+ T cells activated with anti-CD3/CD28 antibodies (hereafter referred to as T H 0 cells). Upon sorting and restimulating proliferating (carboxyfluorescein diacetate succinimidyl ester (CFSE) lo 
) CD4
+ T cells ( Supplementary  Fig. 2a ), CpGA and oxidized mtDNA CD4 + T cells expressed similar proinflammatory chemokine receptors and cytotoxic molecules. They also produced high levels of IFN-γ and low levels of IL-2 ( Fig. 1c,d and Supplementary Fig. 2b ). Oxidized mtDNA CD4 + T cells, however, secreted significantly higher levels of IL-10 and IL-3 ( Fig. 1c,d and Supplementary Fig. 2c ).
In agreement with the reported type 1 helper T cell (T H 1 cell) origin of IFN-γ + IL-10 + T cells, both CpGA and oxidized mtDNA CD4 + T cells expressed the T H 1-associated transcription factors T-bet (encoded by TBX21) and EOMES 12 as well as the chemokine receptor CXCR3 13 ( Fig. 1c and Supplementary Fig. 2d ). Furthermore, knockdown of TBX21 substantially decreased the generation of IFN-γ +
IL-10
+ CD4 + T cells. (Supplementary Fig. 2e ). CpGA-activated pDCs induce anergic CD4 + T cells 8 . Accordingly, CpGA CD4 + T cells proliferated poorly upon reactivation ( Fig. 1e and Supplementary Fig. 2f ). Lack of expression of D-type cyclins and failure to phosphorylate the retinoblastoma tumor suppressor protein (p-Rb) suggested their arrest in the cell cycle G1 phase 14 ( Supplementary Fig. 2g ). On the contrary, oxidized mtDNA CD4 + T cells proliferated vigorously upon reactivation and expressed D-type cyclins and p-Rb ( Fig. 1e and Supplementary Fig. 2f,g ).
A CD4
+ T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate
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As reported for proliferating CD4 + T cells 15 , oxidized mtDNA CD4 + T cells produced higher mitochondrial reactive oxygen species (mtROS) levels than CpGA CD4
+ T cells (Fig. 1f,g and Supplementary Fig. 3a ), and treatment with MitoTempo attenuated their proliferation ( Supplementary Fig. 3b,c) . Complex I of the electron-transport chain is the major site for mtROS production during + T cells upon reactivation with CD3/CD28 (n = 3 independent experiments). f,g, mtROS production by CpGA or oxidized mtDNA CD4 + T cells was assessed by flow cytometry (f; n = 3 independent experiments) or by immunofluorescence microscopy (g; 1 representative of 3 independent experiments). MFI, mean fluoresence intensity. Scale bar, 7 μ m. h, Intracellular (left) and extracellular (right) succinate levels in CpGA or oxidized mtDNA CD4 + T cells (n = 5 independent experiments). Shown are mean ± s.e.m.; statistical analysis by nonparametric one-way ANOVA (a-e) and two-tailed nonparametric unpaired t-test at 95% confidence interval (CI) (f,h). Ox, oxidized.
Letters
NATURE MEDICINE
reverse electron transport (RET), an event characterized by mtROSmediated disintegration of complex I 16 . Indeed, complex I levels were reduced in an mtROS-and mitochondrial protease-dependent manner in oxidized mtDNA CD4 + T cells ( Supplementary Fig. 3d-f ). Complex I degradation leads to decreased complex I-mediated respiration 17 ( Supplementary Fig. 3g ), which can be compensated by higher complex II activity ( Supplementary Fig. 3h ). Indeed, we detected similar maximal respiration rates in CpGA and oxidized mtDNA CD4 + T cells ( Supplementary Fig. 3i ). RET is induced upon succinate accumulation 18 . Accordingly, oxidized mtDNA CD4 + T cells produced and secreted higher levels of succinate than CpGA CD4 + T cells (Fig. 1h) . As succinate accumulation leads to hypoxiainducible factor 1α (HIF-1α ) stabilization 19 , HIF-1α was upregulated in oxidized mtDNA compared with CpGA CD4 + T cells ( Supplementary Fig. 4a ).
Constitutive activation of mechanistic target of rapamycin (mTOR) in systemic lupus erythematosus (SLE) T cells leads to ROS production 20 . As expected, rapamycin reduced the ability of naive CD4
+ T cells to proliferate and differentiate into IFN-γ + IL-10 + T cells in response to oxidized mtDNA-activated pDCs ( Supplementary  Fig. 4b ). Decreased proliferation as well as mtROS and cytokine production also occurred upon restimulation of oxidized mtDNA CD4 + T cells in the presence of rapamycin ( Supplementary Fig. 4c ). In line with their capacity to produce high IL-10 levels, oxidized mtDNA CD4
+ T cells support IL-10-dependent differentiation of naive B cells into plasmablasts 21, 22 ( Fig. 2a,b ). Contrary to T FH cells 23 , however, these cells do not express CXCR5, Bcl-6 or IL-21 ( Supplementary Fig. 5a,b) . Instead, CXCR4 expression suggests a role in extrafollicular B cell responses. Yet, CpGA CD4 + T cells also produce IL-10 but are weaker B cell helpers. Because succinate modulates immune functions upon binding to the succinate receptor (SUCNR1) 24 , which is expressed by all major human blood B cell subsets (Fig. 2c) , we tested its B cell helper capacity. Indeed, blocking SUCNR1 partially inhibited oxidized mtDNA CD4 + T cell-driven B cell activation (Fig. 2d) . Importantly, high levels of immunoglobulin M (IgM) and IgG were detected in cocultures of CpGA CD4 + T cells and B cells supplemented with succinate ( Supplementary Fig. 5c ). Finally, succinate synergized with IL-10 in promoting immunoglobulin secretion by naive B cells activated in vitro with CD40L ( Supplementary Fig. 5d ).
To identify the signals leading to succinate accumulation in oxidized mtDNA CD4
+ T cells, we analyzed expression of co-stimulatory (CD28 and inducible T cell co-stimulator) and co-inhibitory (cytotoxic T lymphocyte-associated antigen 4 and programmed death 1 (PD1)) receptors known to modulate T cell metabolism 25, 26 .
Oxidized mtDNA CD4
+ T cells expressed higher PD1 levels ( Supplementary Fig. 5e ), and PD1 ligation was necessary for succinate and mtROS production as well as for acquisition of B cell helper function ( Fig. 2e and Supplementary Fig. 5f-h ).
As oxidized mtDNA is released upon activation of SLE neutrophils 3 , we next explored whether cells with the phenotype of oxidized mtDNA CD4 + T cells were present in SLE blood. Indeed, CXCR3
+ T cells were significantly expanded in the SLE memory (CD45RA − ) non-T FH (CXCR5 − ) CD4 + T cell compartment (Fig. 3a) Supplementary Fig. 6a ). Among them, CXCR3
+ PD1 hi CD4 + T cells and T FH cells were equally effective at inducing naive and memory B cell differentiation into IgGproducing plasmablasts (Fig. 3b,c and Supplementary Fig. 6b,c) .
Upon T cell receptor stimulation, SLE blood T FH cells produced significant amounts of IL-21, CXCL13 and IL-2, while CXCR3
+ T cells released the highest levels of IL-10 but no IL-21 or CXCL13 (Fig. 3d and Supplementary Fig. 6d ). Similar results were obtained upon contact with naive or memory B cells (Supplementary Fig. 6e ). Furthermore, CXCR3
+ T cells produced the highest levels of IFN-γ , IL-3, mtROS and succinate ( Fig. 3d-f 
CD4
+ T cells upregulated chemokine receptors such as CCR2, CCR5 and CX3CR1 ( Fig. 3i and Supplementary Fig. 6f ). In addition, transcripts (GZMA, GZMB, PRF1, GZMH, GNLY, CTSW, FCRL6, S1PR5, SLAMF7 and NKG7) as well as transcription factors linked to cytotoxic programs 29 (ZNF683, RUNX3, EOMES and TBX21) were exclusively upregulated in CXCR3 Fig. 3i and Supplementary Fig. 6g ). Gene ontology analysis identified additional gene sets involved in cell cycle regulation, including cyclins (CCNE2, CCNB1, CCNB2 and CCNA2), cyclindependent kinases (CDK1) and elongation factors (E2F1 and E2F2) as the top differentially expressed genes ( Supplementary Fig. 6h) Fig. 7a ). On the contrary, CXCR3 + PD1 hi CD4 + T cell frequency was positively correlated with IgG and IgA levels (Fig. 4a) . As previously reported 31, 32 , plasmablasts were expanded in our subjects' blood. A correlative trend between plasmablast and CXCR3 + PD1 hi CD4 + T cell frequencies was found, but it did not reach statistical significance ( Supplementary Fig. 7b ,c), most likely owing to plasmablast fragility during cryopreservation. In addition to plasmablasts, ageassociated B cells (ABCs) have been reported in SLE 33, 34 . This cell population was expanded in our pediatric subjects, and the frequency of these cells was correlated with that of CXCR3 + PD1 hi CD4 + T cells (Fig. 4b,c) . Lupus nephritis (LN), which comprises several histological classes, is one of the major drivers of morbidity and mortality in SLE. As conventional markers of kidney function are not LN class specific, we asked whether blood CXCR3
+ T cells would represent a LN biomarker. When correlated with clinical and laboratory data, the highest frequency and absolute numbers of blood CXCR3
+ T cells were detected in individuals with no LN or with LN class not associated with lymphocytic infiltration in the kidney (LN class II; Fig. 4d and Supplementary Fig. 7d ). Conversely, the lowest frequency was found in individuals with proliferative lupus nephritis (PLN; LN classes III and IV), the most severe form of LN in children. This distribution was not driven by immunosuppressive therapy ( Supplementary Fig. 7e ).
Because lower numbers of blood CXCR3 + PD1 hi CD4 + T cells in PLN might reflect their migration into the kidney, tissue sections from individuals with SLE without LN and with different LN classes were analyzed by immunofluorescence. Different degrees of CD3 + T cell infiltrates were detected in the peritubular areas of a significant fraction (13/17) of PLN sections ( Supplementary Fig. 7f,g ). Across . The cells that we describe herein produce neither IL-21 nor CXCL13 and exhibit a distinctive transcriptome and chromatin landscape compared with T FH cells. Importantly, they help B cells through a unique mechanism involving IL-10 and succinate.
New roles for succinate, an intermediate of the tricarboxylic acid cycle, outside metabolism have recently emerged, including its synergism with lipopolysaccharide to induce IL-1β production by macrophages 24 . The effects of succinate on innate immunity are well recognized, and this report implicates it in the shaping of adaptive immune responses as well.
B and T cells are a prominent feature of PLN infiltrates 36 . Individuals with PLN, however, carry the lowest numbers of blood CXCR3
+ T cells are found in the peritubular areas in close proximity to B cells. Of note, SUCNR1 is expressed in a variety of tissues, especially in the kidney. Within this organ, the highest receptor density is found in the proximal tubular epithelium. There, triggering of the receptor leads to release of renin from the juxtaglomerular apparatus. Consequently, succinate has been implicated in the pathogenesis of diabetic nephropathy and renovascular hypertension 38 . Whether T cell-derived succinate directly contributes to kidney damage in PLN, the main class of LN associated with renovascular hypertension, deserves further study. + T cells and naive B cell cocultures (n = 6 independent experiments). c, Immunoblot analysis of SUCNR1 expression by purified human B cell subsets (n = 3 independent experiments). d, IgM and IgG levels in the supernatants from oxidized mtDNA CD4
+ T cell and naive B cell cocultures in the presence of anti-SUCRN1 (n = 3 independent experiments). e, IgM and IgG levels in the supernatants from cocultures of oxidized mtDNA CD4 + T cells, generated in the presence of isotype control or anti-PD1, and naive B cells (n = 3 independent experiments). Shown are mean ± s.e.m.; statistical analysis by nonparametric one-way ANOVA (b) and two-tailed nonparametric unpaired t-test at 95% CI (a,d,e). 
C o n t r o l a n t i -I L -1 0 a n t i -I L -2 1 R a n t i -S U C R N 1 C o n t r o l a n t i -I L -1 0 a n t i -I L -2 1 R a n t i -S U + T cells compared with T FH cells (EdgeR, adjusted P value < 0.05 and fold change > 2). Shown are mean ± s.e.m.; statistical analysis by nonparametric one-way ANOVA (a-c,g) and two-tailed nonparametric unpaired t-test at 95% CI (d-f). PC, principal component.
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The novel CD4
+ T cell population that we describe, which we propose to designate as T H 10 cells, expands the spectrum of B cell helper T cells and might contribute to SLE pathogenesis and end organ damage in a variety of ways. These cells provide unique mechanistic clues for therapeutic intervention in a disease for which only one new drug has been approved in more than 60 years. Healthy pediatric control samples were obtained via an institutional review board-approved protocol from children whose parents/guardians completed a questionnaire indicating that the child (i) had no chronic illness and (ii) had not been ill, received any vaccinations or suffered from seasonal allergies at the time of blood collection or during the month beforehand. Renal biopsies (formalin-fixed paraffin-embedded) from healthy controls (n = 6) or from subects displaying class II (n = 4), class III (n = 9) or class IV (n = 8) LN, as defined by the International Society of Nephrology/Renal Pathology Society revised LN classification criteria, who on review of records fulfilled the American College of Rheumatology revised criteria for the classification of SLE 39, 40 were obtained from Pathologists Bio-Medical Laboratories (Lewisville, TX). All relevant ethical regulations were followed while conducting this work. 
CD4
+ CD45RA − CXCR5 − cell fraction. Where described, CD3
+ T cells (T FH cells) were also sorted for comparison. Cell sorting was performed on a BD FACSAria Fusion or BD FACSMelody cell sorter using a 100-μ m nozzle. Sort gates were drawn as depicted in Supplementary Figs. 2a and 6a. Cell purity was routinely > 98%. For functional analyses, cells were sorted into cold RPMI/10% FBS. For RNA analyses, sorted cells were lysed in RLT lysis buffer (Qiagen) with 1% β -mercaptoethanol (Sigma-Aldrich).
Oxidized mtDNA generation and pDC activation. Oxidized mtDNA was generated as previously described 3 . Briefly, healthy neutrophils were pre-incubated with IFN-α 2β (2,000 U ml ; Schering) for 90 min at 37 °C and then extensively washed before incubation with anti-RNP IgG (50 μ g ml pDC analysis. pDCs were cultured as described in the previous section, and cytokine levels in the corresponding supernatants were measured with the Flex Set Kit (BD Biosciences). For flow cytometry analysis, cells were stained with anti-CD80 APC (clone L307), anti-CD86 PE (clone FUN-1), anti-CD83 FITC (clone HB15e), anti-CD40 PE (clone 5C3), anti-HLA-DR APC-H7 (clone G46-6), anti-CD123 PE (clone 9F5), anti-CXCR4 PE-Cy7 (clone 12G5), anti-CXCR3 Brilliant Violet 785 (clone GO25H7) or anti-CCR7 APC (clone 3D12). To assess the effect of IL-3 on cell viability, activated pDCs were treated with recombinant human IL-3 (50 ng ml
; BD Biosciences), cultured for an additional 24 h and then stained with the annexin V-apoptosis detection kit (BD Biosciences) following the manufacturer's instructions.
Migration assay. For Transwell-migration assays, 5 × 10 4 activated pDCs were applied in 100 μ l cRPMI to 6.5-mm-diameter Transwell inserts that were separated from the lower chamber by polycarbonate membranes containing 5-μ m pores (Costar). The lower compartments were filled with cRPMI and 1 μ g ml −1 CCL19 or CCL21 (R&D Systems). Cells were then allowed to migrate through the bottom of the chamber for 18 h. The number of transmigrated cells relative to input was then measured. Proliferation assay. CD4 T cell proliferation was measured by resazurin reduction, as previously described 41 . Briefly, primed (CFSE lo ) CD4
CD4 T cell differentiation
+ T cells were seeded at 5 × 10 5 cells and re-stimulated with 10 μ g ml −1 plate-bound anti-CD3 (clone OKT3; BioLegend) and 2 μ g ml −1 soluble anti-CD28. After incubation for 20 h, medium supplemented with 40 μ M resazurin was added for an additional 4 h. Resazurin reduction to resorufin was measured fluorometrically using a SpectraMax M5 (Molecular Devices). Results obtained were expressed in fluorescence arbitrary units (AU). Alternatively, proliferation was assessed by flow cytometry using the Click-IT EdU Flow Cytometry Proliferation Kit, according to the manufacturer's instructions (Thermo Fisher Scientific).
In vitro T FH cell generation. Human T FH cells were generated as previously described 42 . Briefly, after overnight stimulation of naive CD4 + T cells with Dynabeads human T cell activator CD3/CD28 (Thermo Fisher Scientific) in complete RPMI medium, cells were transferred to 96-well plates coated with anti-CD3 and supplemented with 2 μ g ml −1 soluble anti-CD28 (BioLegend), human recombinant IL-23 (25 ng ml ; clone JES3-9D7; BioLegend LEAF purified antibody), anti-SUCNR1/ GPR91 (20 μ g ml ; Novus Biological), anti-IL-21R (10 μ g ml ; clone 17A12; BioLegend LEAF purified antibody) or succinate (2 mM; Sigma-Aldrich) was added during the coculture. Sodium azide and other preservatives were removed from the antibody preparations by protein desalting with Zeba Spin Desalting Columns (7 K MWCO; Thermo Fisher Scientific). IgM and IgG concentrations were measured at day 12 in the corresponding supernatants with the Flex Set Kit (BD Biosciences). For T cell-independent B cell differentiation, naive B cells (5 × 10 4 cells) were cocultured with irradiated (77 Gy) human CD40L-transfected fibroblasts 43 (0.5 × 10 4 cells) in cRPMI supplemented with 10% heat-inactivated FBS. Recombinant human IL-10 (500 ng ml −1 ; BioLegend) and/or succinate (2 mM; Sigma-Aldrich) was added during the cocultures IgG and IgM concentrations were Letters NATURE MEDICINE measured at day 12 in the corresponding supernatants with the Flex Set Kit (BD Biosciences).
Immunofluorescence microscopy. Cells were settled on poly-l-lysine-coated glass coverslips for 20 min at 37 °C, rinsed with PBS and then fixed with 4% paraformaldehyde for 20 min at room temperature. Cells were permeabilized with 0.05% Triton X-100 in PBS for 5 min at room temperature and then treated with blocking buffer (5% goat serum and 1% BSA in PBS) for 30 min at room temperature. Primary (anti-p65; catalog number ab16502; Abcam) and secondary antibody stainings were carried out in staining buffer (1% BSA in PBS). Isotypespecific anti-mouse or anti-rabbit Alexa Fluor 488 or Alexa Fluor 568 was used as the secondary antibody. Counterstaining of cell nuclei was performed with Hoechst stains (Molecular Probes). Samples were mounted with ProLong Gold Antifade Reagent (Molecular Probes) and examined with a Leica TCS SP5 confocal laser-scanning microscope equipped with a 63× /1.4 oil objective. ImageJ software (National Institutes of Health) was used for analysis. The percentage of colocalization was calculated from the Manders overlap coefficient using the ImageJ 'co-localization analysis' plug-in (National Institutes of Health). Short interfering RNA knockdown. Knockdown of TBX21 in primary human naive CD4 + T cells was done using ACCELL short interfering RNA (siRNA) SMARTpool, designed and validated by Dharmacon. A nontargeting siRNA was used as negative control. Freshly sorted allogeneic naive CD4 + T cells (12 × 10 4 ) were activated with pDCs (pDC:T cell ratio of 1:6) for 24 h before adding 1 μ M of ACCELL siRNA. Cells were restimulated 96 h after transfection with 50 ng ml
Ionomycin and GolgiPlug (BD Biosciences) for 5 h and analyzed for intracellular cytokine production as described above. Protein knockdown was validated by flow cytometry.
Microarray analysis of pDCs. Total RNA was isolated using the RNeasy Kit (Qiagen), amplified and then labeled with the Illumina TotalPrep RNA Amplification Kit (Invitrogen). The Agilent 2100 Analyzer (Agilent Technologies) was used to assess RNA integrity. Biotinylated complementary RNA (cRNA) was hybridized to Illumina Human-6 Beadchip Array version 2 and scanned on the Illumina Beadstation 500. Fluorescent hybridization signals were assessed with Beadstudio software (Illumina), and statistical analysis and hierarchical clustering were performed with GeneSpring 7.3.1 software (Agilent Technologies).
RNA preparation and sequencing library preparation. Total RNA was isolated from cell lysates using a modified protocol for the RNAqueous Micro Total RNA Isolation Kit (Thermo Fisher Scientific), including on-column deoxyribonuclease digestion, and was analyzed for quality using the RNA 6000 Pico Kit (Agilent Technologies). For in vitro-generated CD4 + T cells, poly(A)-enriched nextgeneration sequencing library construction was performed using the KAPA mRNA Hyper Prep Kit (KAPA Biosystems) with 500 ng of input total RNA and 9 amplification cycles according to the manufacturer's protocol. Individual libraries were quantitated via quantiative PCR using the KAPA Library Quantification Kit, Universal (KAPA Biosystems) and equimolar pooled. Final pooled libraries were sequenced on an Illumina NextSeq 500 with paired-end 75-base-pair (bp) read lengths. For ex vivo-isolated CD4 + T cells, next-generation sequencing library construction was performed using the SMART-Seq v4 Ultra Low Input RNA Kit (Clontech) with 2 ng of input total RNA and 12 amplification cycles according to manufacturer's protocol to generate cDNA. Sequencing libraries were prepared using the Nextera XT DNA Library Prep Kit (Illumina) using 150 pg of cDNA according to the manufacturer's protocol. Individual libraries were quantitated using the Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific) and equimolar pooled. Final pooled libraries were sequenced on an Illumina NextSeq 500 with paired-end 75-bp read lengths.
RNA sequencing data processing and analysis. Quality control of raw reads was performed with FASTQC. Reads were aligned to the reference human genome (GRCh38) using hisat2 after quality and adapter trimming by cutadapt. After sorting binary alignment map files by name using samtools, the HTSeq-count program was used to quantify total numbers of read counts mapped to the genome. The RNA sequencing data analysis was performed in the R programming language. The DESeq2 R package was used for size factor and dispersion estimation calculation and differential gene expression analysis.
ATAC-seq library generation and sequencing. Assay for transposase accessible chromatin sequencing (ATAC-seq) was performed as previously described 30 . Unfixed nuclei (20,000) were tagged using Tn5 transposase (Nextera DNA Sample Prep Kit; Illumina) for 30 min at 37 °C, and the resulting library fragments were purified using a MinElute Kit (Qiagen). Libraries were amplified by 10-12 PCR cycles, purified using a PCR Cleanup Kit (Qiagen) and finally sequenced on an Illumina HiSeq 2500 with 75-bp paired-end reads to a minimum depth of 30 million reads per sample. At least two technical replicates were processed per biological sample.
ATAC-seq preprocessing and bioinformatics analysis. Reads were trimmed using trimmomatic 44 and mapped to the GRCh37/hg19 assembly of the human genome using bwa-mem 45 . Duplicate reads were removed using samtools, and technical replicates were merged into a single binary alignment map file. Peak calling was performed using MACS2 with the paramters '--nomodel --shift 37 --extsize 73 --broad' , and only peaks with q < 0.05 were selected. Peaks overlapping blacklisted regions as defined by the ENCODE project were discarded. Consensus peaks present in at least two samples were obtained using the DiffBind R package. Peaks were annotated to the closest transcription start sites in the University of California, Santa Cruz, hg19 knownGene transcriptome using the ChIPSeeker R package 46 . Peaks with differential chromatin accessiblility were found using a generalized linear model in EdgeR using the population as covariate. Genome tracks of read coverage per bp and per million mapped reads were generated using HOMER 47 makeUCSCfile with the parameters '--res 1 --norm 1e6' and were visualized with the IGV genome browser. + T cells were sorted and loaded for 30 min at 37 °C with MitoSox Red (2.5 μ M; Thermo Fisher Scientific) and MitoTraker Deep Red (25 nM; Thermo Fisher Scientific). Cells were then re-stimulated with 10 μ g ml −1 plate-bound anti-CD3 (clone OKT3; BioLegend) and 2 μ g ml −1 soluble anti-CD28 (BioLegend) for 1 h. Cells were then washed and subjected to flow cytometry analysis or immunofluorescence microscopy. Alternatively, total peripheral blood mononuclear cells from healthy donors or individuals with SLE were loaded for 30 min at 37 °C with MitoSox Red (2.5 μ M; Thermo Fisher Scientific). Cells where then stained as described above and analyzed by flow cytometry. Seahorse assays. Complex I-and complex II-linked mitochondrial respiration was determined using a modified version of a previously described method 48 . Briefly, XF-24 cell culture microplates (Seahorse Bioscience) were coated with Cell-Tak (50 μ L at 22.4 μ g mL ; Corning), and primed (CFSE lo ) CD4
+ T cells (15 × 10 4 ) were plated in MAS-BSA assay solution (220 mM mannitol, 70 mM sucrose, 10 mM KH 2 PO 4 , 5 mM MgCl 2 , 2 mM HEPES, 1 mM EGTA, 0.2% fatty acid-free BSA) containing XF Plasma Membrane Permeabilizer (2 nM; Seahorse Bioscience) and ADP (4 mM; Santa Cruz Biotechnology). Complex I activity was assessed by measuring the oxygen consumption rate (OCR) in response to the complex I substrate pyruvate (10 mM; Sigma-Aldrich). Malate (5 mM; Sigma-Aldrich) was added together with pyruvate to allow oxaloacetate production and condensation with acetyl coenzyme A, allowing normal pyruvate dehydrogenase flux 48 . Complex II (succinate dehydrogenase, SDH) activity was assessed by measuring the OCR in response to the complex I substrate succinate (10 mM; Sigma-Aldrich). Rotenone (2 μ M; Sigma-Aldrich) was added togheter with succinate to prevent accumulation of oxaloacetate, which is a potent inhibitor of SDH 48 . For maximal respiration Letters NATURE MEDICINE rate measurement, the assay was performed in Seahorse medium (DMEM supplemented with 2 mM glutamine, 25 mM glucose and 1 mM pyruvate). Maximal respiration rate was defined as the OCR after the addition of oligomycin (2 μ M; Sigma-Aldrich) and FCCP (2 μ M). All extracellular flux analyses were performed using an XF-24 Extracellular Flux Analyzer (Seahorse Bioscience) as recommended by the manufacturer.
Immunofluorescence of paraffin-embedded kidney sections. Tissue sections were deparaffinized in xylene for 10 min, washed with 100% ethanol followed by 95%, 80%, 70% and 50% ethanol, and then rinsed in distilled water. For antigen retrieval, tissue sections were boiled for 10 min in 10 mM sodium citrate buffer (pH 6.0) containing 0.05% Tween 20. After two washes with distilled water and two washes with PBS, tissue sections were permeabilized for 30 min at room temperature in PBS/0.1% Triton X-100. Sections were blocked for 1 h at room temperature in blocking buffer (PBS/1% BSA/0.5% Fish Gelatin/5% goat serum) and then incubated overnight at 4 °C with the primary antibody diluted in blocking buffer. Anti-CD3 (clone OKT3; biolegend), anti-IL-10 (Clone A47-25-17; Abcam), anti-IFN-γ (catlog number ab25101; Abcam), anti-nitrotyrosine (catalog number ab42789; Abcam), anti-CD20 (clone EP459Y; Abcam), anti-CD4 (clone EPR6855; Abcam), anti-PD1 (clone EPR4877; Abcam) and anti-aquaporin1 (clone B-11; Santa Cruz Biotechnology) were used as primary antibodies. Tissue sections were then probed with Alexa Fluor-conjugated secondary antibodies, diluted in blocking buffer, at room temperature for 60 min. Counterstaining of cell nuclei in tissue sections was performed with the Hoechst stains (Thermo Fisher Scientific). Samples were then mounted with ProLong Gold Antifade Reagent (Thermo Fisher Scientific). Digital images were taken using an LSM 880 confocal microscope with an Airyscan High Resolution Detector (Carl Zeiss Microscopy). ImageJ software (National Institutes of Health) was used for data analysis. 
Statistical analysis.
No specific statistical methods were used to predetermine sample size. All results are presented as the mean ± s.e.m. The significance of the difference between groups was analyzed as described in the figure legends. Pearson's correlation coefficients with two-tailed P values were determined in the analysis of correlations. P values < 0.05 were considered statistically significant. All statistical analyses were performed using GraphPad Prism Software version 7.0e.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
Expression array data from pDCs is available at the Gene Expression Omnibus (GEO) database under accession GSE93679. Expression array data from in vitrogenerated CD4
+ cells is available at the GEO database under accession GSE118951. Expression array data from ex vivo-isolated CD4 + cells is available at the GEO database under accession GSE109843. ATAC-seq data is available at the GEO database under accession GSE110017. Uncropped data for Supplementary Fig. 2g can be accessed in Supplementary Fig. 8a . All other relevant data are available from the corresponding author directly.
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Data analysis
Statistical analysis was performed using GraphPad Prism v7.0. Flow cytometry data were analyzed with FlowJo v10.4.2. Microarray data were analyzed with GeneSpring v7.3.1. Softwares used in RNAseq and ATACseq data analysis: Trimmomatic (v0.33), Samtools (v0.1.19), bwa-mem (v0.7.12), MACS (v2.1.0), R (v3.3.1), DiffBind (v2.0.9), EdgeR (v3.14.0), HOMER (v4.6), IGV (v2.3.77) and DESeq2 (v1.16.1).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
